{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:16:00Z","timestamp":1789647360025,"version":"4.0.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["22ONRC18"],"award-info":[{"award-number":["22ONRC18"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370168"],"award-info":[{"award-number":["82370168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8246010433"],"award-info":[{"award-number":["8246010433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170168"],"award-info":[{"award-number":["82170168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["GYFYNSFC (2024)-47"],"award-info":[{"award-number":["GYFYNSFC (2024)-47"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148750","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:12:54Z","timestamp":1762272774000},"page":"148750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Exosomal microRNA-20b-5p contributes to cytarabine resistance in acute myeloid leukemia via the microtubule-associated serine\/threonine kinase-like\u2013phosphatidylinositol 3-kinase\u2013protein kinase B signaling axis"],"prefix":"10.1016","volume":"333","author":[{"given":"Aoshuang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiWei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiumei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148750_bb0005","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41375-025-02539-0","article-title":"CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents","volume":"39","author":"Reuvekamp","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41375-025-02536-3","article-title":"How fast does leukemia progress?","volume":"39","author":"Giudice","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0020","series-title":"Chemotherapy Resistance in Acute Myeloid Leukemia Is Mediated by A20 Suppression of Spontaneous Necroptosis","first-page":"9189","volume":"15","author":"Culver-Cochran","year":"2024"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0025","article-title":"Extracellular vesicles carry distinct proteo-transcriptomic signatures that are different from their cancer cell of origin","volume":"25","author":"Chen","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0035","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.7150\/thno.20576","article-title":"Role of extracellular vesicles in viral and bacterial infections: pathogenesis, diagnostics, and therapeutics","volume":"8","author":"Rodrigues","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/1471-0528.17446","article-title":"The diagnostic and therapeutic prospects of exosomes in ovarian cancer","volume":"130","author":"Chen","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0050","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41598-025-85690-z","article-title":"Expression and characterization of exosomal miRNAs in healthy, sub-clinical mastitis and pasteurized milk of buffaloes","volume":"15","author":"Yoshitha","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0055","first-page":"2479","article-title":"Milk exosomes: nature\u2019s abundant nanoplatform for theranostic applications","volume":"6","author":"Adriano","year":"2021","journal-title":"Bioact Mater."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","article-title":"Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis","volume":"29","author":"Xie","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0070","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.3390\/ijms25073914","article-title":"MicroRNAs in pancreatic cancer: advances in biomarker discovery and therapeutic implications","volume":"25","author":"Madadjim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/2211536612666230413125126","article-title":"Revisiting inhibition effects of miR-28 as a metastasis suppressor in gastrointestinal cancers","volume":"12","author":"Razi Soofiyani","year":"2023","journal-title":"MicroRNA"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202402058","article-title":"Exosome-based theranostic for gastrointestinal cancer: advances in biomarker discovery and therapeutic engineering","volume":"9","author":"Mehta","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/biomedicines12030691","article-title":"Functions of differentially regulated miRNAs in breast cancer progression: potential markers for early detection and candidates for therapy","volume":"12","author":"Subramanian","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115911","article-title":"Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R- PI3K\/AKT\/mTOR and MEK\/ERK pathways to inhibit colorectal cancer progression","volume":"169","author":"Jassi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0100","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers16122285","article-title":"Exploring miRNA profiles in colon cancer: a focus on miR101-3p, miR106a-5p, and miR326","volume":"16","author":"T\u00e2lvan","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/00220345231216110","article-title":"CaCO3 nanoparticles delivering microRNA-200c suppress oral squamous cell carcinoma","volume":"103","author":"Ding","year":"2024","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0110","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/cancers16233948","article-title":"Potential use of exosomal non-coding microRNAs in leukemia therapy: a systematic review","volume":"16","author":"Gil-Kulik","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306962","article-title":"Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers","volume":"19","author":"Kang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10020-021-00393-1","article-title":"Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p\/TRIM14 pathway","volume":"27","author":"Cheng","year":"2021","journal-title":"Mol Med Camb Mass."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0125","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/iub.2273","article-title":"MicroRNA-34a-mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting","volume":"72","author":"Hu","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0130","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/biom12101448","article-title":"Exosomal miR92a promotes cytarabine resistance in myelodysplastic syndromes by activating Wnt\/\u03b2-catenin signal pathway","volume":"12","author":"Li","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154731","article-title":"A snapshot of miRNAs in oral squamous cell carcinoma: difference between cancer cells and corresponding normal cells","volume":"249","author":"Hosseini","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12964-022-01019-7","article-title":"The dual role of microRNA (miR)-20b in cancers: friend or foe?","volume":"21","author":"\u0130lhan","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-022-01242-1","article-title":"Tumor-derived miR-20b-5p promotes lymphatic metastasis of esophageal squamous cell carcinoma by remodeling the tumor microenvironment","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0150","first-page":"137","article-title":"Regulation of BTG3 by microRNA-20b-5p in non-small cell lung cancer","volume":"18","author":"Peng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3892\/ol.2022.13546","article-title":"miR-20b-5p is a novel biomarker for detecting prostate cancer","volume":"24","author":"Zhai","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0160","first-page":"16","article-title":"Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML","volume":"8","author":"Li","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0165","article-title":"MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2017.00255","article-title":"microRNAs and acute myeloid leukemia chemoresistance: a mechanistic overview","volume":"7","author":"Gabra","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/cancers12020496","article-title":"Increased expression of micro-RNA-23a mediates chemoresistance to cytarabine in acute myeloid leukemia","volume":"12","author":"Hatzl","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2017.09.014","article-title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","volume":"62","author":"Bouvy","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104459","article-title":"MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1\/OCT4 levels","volume":"25","author":"N\u00e4rv\u00e4","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-018-0848-3","article-title":"MASTL induces colon cancer progression and chemoresistance by promoting Wnt\/\u03b2-catenin signaling","volume":"17","author":"Uppada","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0195","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1182\/blood-2024-207505","article-title":"Mastl is a new therapeutic target for acute myeloid leukemia","volume":"144","author":"Chen","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102861","article-title":"PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer","volume":"132","author":"Hao","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MPH.0000000000000329","article-title":"PI3King the lock: targeting the PI3K\/Akt\/mTOR pathway as a novel therapeutic strategy in neuroblastoma","volume":"37","author":"King","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0210","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.3390\/jcm9092934","article-title":"Targeting PI3K\/Akt\/mTOR in AML: rationale and clinical evidence","volume":"9","author":"Darici","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0215","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/ijms21082907","article-title":"The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells","volume":"21","author":"Nepstad","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0220","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7150\/ijms.102266","article-title":"NACC1 accelerates the progression of AML by regulating the ADAM9\/PI3K\/AKT axis","volume":"22","author":"Zhang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41419-024-06996-w","article-title":"BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription","volume":"15","author":"Kang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0230","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0235","article-title":"miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database","volume":"48","author":"Huang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"The Innovation"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0245","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0250","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12935-025-03760-8","article-title":"Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease","volume":"25","author":"Ren","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0260","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"Yap","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0265","article-title":"MicroRNA gets a mighty award","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0270","first-page":"4331","article-title":"Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles","volume":"63","author":"Shedden","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0275","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0280","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s10147-022-02161-5","article-title":"Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia","volume":"27","author":"Cao","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.904719","article-title":"The MASTL-ENSA-PP2A\/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma","volume":"10","author":"Gouttia","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0290","article-title":"Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer","volume":"4","author":"Dhital","year":"2023","journal-title":"Cell Rep Med."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0295","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1195689","article-title":"Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis","volume":"330","author":"Mochida","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0300","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1197048","article-title":"The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A","volume":"330","author":"Gharbi-Ayachi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/10409238.2016.1143913","article-title":"PP2A as a master regulator of the cell cycle","volume":"51","author":"Wlodarchak","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0310","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2006.11.033","article-title":"Structure of the protein phosphatase 2A holoenzyme","volume":"127","author":"Xu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature05351","article-title":"Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme","volume":"445","author":"Cho","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molmed.2008.02.001","article-title":"Multiple pathways regulated by the tumor suppressor PP2A in transformation","volume":"14","author":"Westermarck","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0325","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0330","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0335","doi-asserted-by":"crossref","unstructured":"Cordonnier M, Nardin C, Chanteloup G, Derangere V, Algros M-P, Arnould L, et al. Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients. J Extracell Vesicles. 9:1710899. doi:https:\/\/doi.org\/10.1080\/20013078.2019.1710899.","DOI":"10.1080\/20013078.2019.1710899"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0340","author":"Tianjin Medical University Cancer Institute and Hospital"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0350","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110833","article-title":"The MASTL\/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner","volume":"42","author":"Sanz-Castillo","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.148750_bb0355","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie Du Sert","year":"2020","journal-title":"PLoS Biol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025093079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025093079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T17:04:12Z","timestamp":1764435852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025093079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"alternative-id":["S0141813025093079"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148750","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal microRNA-20b-5p contributes to cytarabine resistance in acute myeloid leukemia via the microtubule-associated serine\/threonine kinase-like\u2013phosphatidylinositol 3-kinase\u2013protein kinase B signaling axis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148750"}}